“High-content quantum dot-based subtype diagnosis and classification of breast cancer patients using hypermulticolor quantitative single cell imaging cytometry”
Authors:
- Yu Kyung TakYTYu Kyung Tak
- Pravin K. NaogharePNPravin K. Naoghare
- Byung Joo KimBKByung Joo Kim
- Min Jung KimMKMin Jung Kim
- Eun Sook LeeELEun Sook Lee
- Joon Myong SongJSJoon Myong Song
- 1 August 2012
- journal article
- Published by Elsevier in Nano Today
- Vol. 7 (4) , 231-244
Abstract
No abstract availableKeywords
Funding Information
- National Research Foundation of Korea
- Ministry of Education, Science and Technology (2008-0061858, 2012-0005653)
This publication has 30 references indexed in Scilit:
- The quantitative detection of total HER2 load by quantum dots and the identification of a new subtype of breast cancer with different 5-year prognosisBiomaterials, 2010
- Breast Cancer Classification: Time for a ChangeJournal of Clinical Oncology, 2009
- Quantum dots-based immunofluorescence technology for the quantitative determination of HER2 expression in breast cancerBiomaterials, 2009
- Predictive markers in breast cancer – the presentHistopathology, 2007
- American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast CancerJournal of Clinical Oncology, 2007
- Quantification of immunohistochemistry—issues concerning methods, utility and semiquantitative assessment IIHistopathology, 2006
- Breast Cancer Molecular Subtypes Respond Differently to Preoperative ChemotherapyClinical Cancer Research, 2005
- Comparative multi‐methodological measurement of ERBB2 status in breast cancerThe Journal of Pathology, 2004
- Molecular portraits of human breast tumoursNature, 2000
- Estrogen Receptor Status by Immunohistochemistry Is Superior to the Ligand-Binding Assay for Predicting Response to Adjuvant Endocrine Therapy in Breast CancerJournal of Clinical Oncology, 1999